Our program is arranged around the seven elements of an effective compliance program, as set forth in the voluntary “Compliance Program Guidance for Pharmaceutical Manufacturers,” published in April Office of Inspector General, U.S. Department of Health and Human Service (“HHS-OIG Guidance”).